AstraZeneca PLC is 199.3x more valuable than KalVista Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $1.44 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | KALV | AZN |
|---|---|---|
| Market cap | $1.44 B | $286.27 B |
| US-listed rank | #2363 | #45 |
| Revenue (latest FY) | $50.00M | - |
| Net income (latest FY) | -$183.40M | - |
| Net margin | -366.8% | - |
| SEC filings | 834 | 1,004 |
AstraZeneca PLC is 199.3x more valuable than KalVista Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $1.44 B).
Full pages: KalVista Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.